| Literature DB >> 35453305 |
María Isabel Quirós-Fallas1, Felipe Vargas-Huertas1, Silvia Quesada-Mora2, Gabriela Azofeifa-Cordero2, Krissia Wilhelm-Romero1, Felipe Vásquez-Castro1, Diego Alvarado-Corella1, Andrés Sánchez-Kopper3, Mirtha Navarro-Hoyos1.
Abstract
Curcuma longa constitutes an important source of secondary metabolites that have been associated with multiple health benefits. For instance, curcumin, demethoxycurcumin and bisdemethoxycurcumin, have been found to perform important biological activities, such as anti-inflammatory, antioxidant, anticancer, antimicrobial, antihypertensive and anticoagulant. These promising results prompted this research to evaluate the polyphenols of C. longa rhizomes in Costa Rica. The present work reports a comprehensive study on the polyphenolic profile and the contents of the three main curcuminoids as well as the antioxidant activity of extracts from C. longa rhizomes (n = 12) produced in Costa Rica. Through UPLC-QTOF-ESI MS, a total of 33 polyphenols were identified, grouped in eight types of structures. In addition, our findings on the main curcuminoids using UPLC-DAD show all rhizomes complying with total curcuminoids (TC) content established by the United States Pharmacopeia (USP). At an individual level, samples NW-3 and NE-1 show the higher contents (118.7 and 125.0 mg/g dry material), representing more than twice the average values of the lowest samples. These samples also exhibit the highest Folin-Ciocalteu (FC) reducing capacity results as well as the best DPPH (IC50 15.21 and 16.07 µg extract/mL) and NO (IC50 between 52.5 and 54.3 µg extract/mL) antioxidant values. Further, Pearson correlation analysis findings indicated positive correlation (p < 0.05) between TC, CUR with FC results (r = 0.833 and r = 0.867 respectively) and negative correlation (p < 0.05) between CUR, TC and FC with DPPH results (r = -0.898, r = -0.911, and r = -0.890, respectively) and between NO results and DPPH (r = -0.805, p < 0.05). Finally, results for Principal Component Analysis (PCA) showed composition variability associated with their region of origin with products from the Northeastern (NE) region exhibiting higher average values for FC, TC and antioxidant activities. Further, PCA confirmed that two samples, namely NE-1 and NW-3, stand out by presenting the highest PC1 due to their particularly high TC, CUR and antioxidant activities. Consequently, our findings agree with previous results indicating the importance of C. longa extracts to elaborate products with potential benefits for health, while delivering extracts with higher levels of curcuminoids than previous reports and exhibiting high antioxidant activity.Entities:
Keywords: Curcuma longa; QTOF-ESI MS; UPLC; bisdemethoxycurcumin; curcumin; demethoxycurcumin; medicinal herbs; polyphenols
Year: 2022 PMID: 35453305 PMCID: PMC9030737 DOI: 10.3390/antiox11040620
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
UPLC-DAD quantification of total curcuminoids in turmeric sample NR-1 under various PLE conditions.
| Experiment | Solvent | T (°C) | Static Time (min) | TC 1,2,3 |
|---|---|---|---|---|
| 1 | Methanol | 80 | 10 | 88.6 a,b ± 1.1 |
| 2 | Acetone | 80 | 10 | 90.8 a ± 3.2 |
| 3 | Acetone | 80 | 6 | 86.6 a,b ± 1.3 |
| 4 | Methanol | 80 | 6 | 81.0 b ± 0.8 |
| 5 | Methanol | 60 | 6 | 65.3 c ± 2.8 |
| 6 | Acetone | 60 | 6 | 57.8 c,d ± 3.7 |
| 7 | Acetone | 60 | 10 | 51.9 d ± 4.7 |
| 8 | Methanol | 60 | 10 | 57.7 c,d ± 1.0 |
1 Total Curcuminoids contents (TC) is expressed as mg/g dry material 2 Values are expressed as mean ± standard deviation (S.D.). 3 Different superscript letters indicate differences are significant at p < 0.05 using one-way analysis of variance (ANOVA) with a Tukey post hoc as statistical test.
Figure 1UHPLC QTOF-ESI MS extracted ion chromatograms of curcuminoids from C. longa rhizomes, in a Phenomenex Luna RP18 C-18 column (150 mm × 4.6 mm × 4 µm) using a Xevo G2-XS QTOF Mass spectrometer (Waters™, Wilmslow, UK) in a mass range from 100 to 1000 amu.
Profile of the phenolic compounds identified by UPLC-QTOF-ESI MS in Curcuma longa rhizomes from Costa Rica.
| Peak | Tentative Identification | Rt (min) | Molecular Formula | [M + H]+ Observed | MS2 Fragments | Sample 1 |
|---|---|---|---|---|---|---|
| 1 | 5-hydroxy-1,7-bis(4-hydroxyphenyl)hept-1-en-3-one | 7.39 | C19H21O4 | 313.1422 | 147, 163, 133, 107 | NR-1, NR-2, NE-3, NE-4, NW-1 |
| 2 | 1,5-bis(4-hydroxy-3-methoxyphenyl)pent-1-en-3-one | 8.41 | C19H21O5 | 329.1383 | 137 | NE-1, NE-2, NE-3, NE-4, NW-2, NW-3, WR-1 |
| 3 | 4-(4-hydroxyphenyl)-2-oxobut-3-en-1-yl 3-(4-hydroxyphenyl)acrylate | 11.47 | C19H17O5 | 325.1075 | 147 | NR-1, NR-4, NE-1, NE-2, NE-3, NE-4, NW-3, WR-1 |
| 4 | Tetrahydrobisdemethoxycurcumin | 11.60 | C19H21O4 | 313.1422 | 149, 107 | NR-3, NE-1, NE-3, NE-4, WR-1 |
| 5 | Calebin-A isomer | 11.71 | C21H21O7 | 385.1276 | 177 | NR-2, NR-3, NE-1, NE-3, NE-4, NW-1, NW-2 |
| 6 | 2-(3,4-dihydroxybenzylidene)-5-(-4-hydroxystyryl)furan-3(2H)-one | 11.74 | C19H15O5 | 323.0922 | 123, 147 | NR-2, NR-3, NR-4, NE-1, NE-3, NE-4, NW-2, NW-3, WR-1 |
| 7 | curcumalongin A | 11.83 | C20H17O6 | 353.1024 | 147, 153, 171, 269, 293, 321, 338 | NR-2, NR-3, NR-4, NE-1, NE-2, NE-4, NW-1, NW-3 |
| 8 | curcumalongin B | 12.11 | C21H19O7 | 383.1140 | 123, 145, 153, 177, 201, 294, 350, 368 | NR-2, NR-4, NE-1, NE-2, NE-4, NW-1, NW-3 |
| 9 | 2-(3,4-dihydroxybenzylidene)-5-(4-hydroxy-3-methoxystyryl)furan-3(2H)-one | 12.19 | C20H17O6 | 353.1024 | 123, 150, 153, 177, 337, 338 | NR-1, NR-2, NR-3, NR-4, NE-1, NE-2, NE-3, NE-4, NW-1, NW-2, NW-3, WR-1 |
| 10 | 5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)hept-1-en-3-one | 12.39 | C21H25O6 | 373.1652 | 145, 163, 177, 137 | NR-1, NR-2, NR-3, NR-4, NE-1, NE-2, NE-3, NE-4, NW-1, NW-2, NW-3, WR-1 |
| 11 | 1-(4-hydroxy-3-methoxyphenyl)-5-(4-hydroxyphenyl)penta-1,4-dien-3-one | 13.52 | C18H17O4 | 297.1105 | 107, 119, 137, 145, 147, 173, 177 | NR-1, NR-3, NE-1, NE-2, NE-4, NW-3 |
| 12 | 1,5-bis(4-hydroxy-3-methoxyphenyl)-1,4-pentadien-3-one | 13.97 | C19H19O5 | 327.1216 | 137, 145, 177 | NR-1, NE-1, NE-2, NE-3, NE-4, NW-1, NW-2, NW-3, WR-1 |
| 13 | 1,7-bis(4-hydroxyphenyl)-1,4,6-heptatrien-3-one | 15.13 | C19H17O3 | 293.1167 | 107, 131, 147, 173, 199, 225 | NR-1, NR-2, NR-4, NE-1, NE-2, NE-3, NE-4, NW-1, NW-2, WR-1 |
| 14 | 1-(4-hydroxyphenyl)-7-phenylhept-1-ene-3,5-dione | 15.52 | C19H19O3 | 295.1313 | 105, 119, 147 | NR-1, NR-2, NR-3, NR-4, NE-1, NE-2, NE-4, NW-1, NW-2, NW-3, WR-1 |
| 15 | 1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)hepta-1,4,6-trien-3-one | 15.67 | C20H19O4 | 323.1253 | 107, 131, 137, 161, 177, 229 | NR-2, NR-3, NE-1, NE-2, NE-3, NE-4, NW-1, NW-3 |
| 16 | 1,7-bis(4-hydroxy-3-methoxyphenyl)-1,4,6-heptatrien-3-one | 16.18 | C21H21O5 | 353.1370 | 137, 145, 161, 177, 225 | NR-1, NR-4, NE-1, NE-2, NE-3, NE-4, NW-2, NW-3 |
| 17 | Curcumalongin C | 16.21 | C21H21O7 | 385.1276 | 117, 133, 145, 161, 177, 193, 195, 219 | NR-1, NR-2, NE-1, NE-2, NE-3, NE-4, NW-2, NW-3, WR-1 |
| 18 | 7-(3,4-dimethoxyphenyl)-1-(4-hydroxyphenyl)hept-1-ene-3,5-dione | 16.46 | C21H23O5 | 355.1512 | 119, 147 | NR-2, NE-1, NE-2, NE-4, NW-1 |
| 19 | 2-(4-hydroxy-3-methoxybenzylidene)-5-(-4-hydroxy-3-methoxystyryl)furan-3(2H)-one | 16.56 | C21H19O6 | 367.1176 | 137, 177, 201, 323 | NR-1, NR-2, NR-3, NR-4, NE-1, NE-2, NE-3, NE-4, NW-1, NW-2, NW-3, WR-1 |
| 20 | Octahydrobisdemethoxycurcumin | 17.25 | C19H25O4 | 317.1733 | 107, 147, 161, 281 | NR-2, NR-3, NE-1, NE-2, NE-4, NW-1 |
| 21 | 7-(3,4-dimethoxyphenyl)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)hept-1-en-3-one | 17.75 | C22H27O6 | 387.1826 | 145, 177, 219 | NR-1, NR-3, NE-1, NE-4, NW-3 |
| 22 | Bisdemethoxycurcumin | 17.90 | C19H17O4 | 309.1137 | 147, 225 | NR-1, NR-2, NR-3, NR-4, NE-1, NE-2, NE-3, NE-4, NW-1, NW-2, NW-3, WR-1 |
| 23 | 1,7-bis(3,4-dihydroxyphenyl)-5-hydroxyhept-1-en-3-one | 18.18 | C19H21O6 | 345.1336 | 161, 149, 123, 147 | NR-1, NR-2, NR-4, NE-1, NE-2, NE-3, NE-4, NW-1, NW-2, NW-3, WR-1 |
| 24 | Dihydrodemethoxycurcumin | 18.43 | C20H21O5 | 341.1379 | 119, 145, 147, 177 | NR-2, NR-3, NE-1, NE-4, NW-2, NW-3 |
| 25 | Demethoxycurcumin | 18.46 | C20H19O5 | 339.1262 | 117, 119, 131, 145, 147, 177, 195, 223 | NR-1, NR-2, NR-3, NR-4, NE-1, NE-2, NE-3, NE-4, NW-1, NW-2, NW-3, WR-1 |
| 26 | Artamenone | 18.51 | C17H17O3 | 269.1168 | 119, 107 | NR-2, NR-3, NE-1, NE-4, NW-1, NW-3 |
| 27 | 1-(4-hydroxy-3,5-dimethoxyphenyl)-7-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3, 5-dione | 18.61 | C22H23O7 | 399.1408 | 145, 147, 161, 177, 209 | NR-1, NR-2, NR-4, NE-1, NE-2, NE-3, NE-4, NW-1, NW-2, NW-3 |
| 28 | Curcumin | 19.03 | C21H21O6 | 369.1358 | 117, 145, 161, 177, 219, 225 | NR-1, NR-2, NR-3, NR-4, NE-1, NE-2, NE-3, NE-4, NW-1, NW-2, NW-3, WR-1 |
| 29 | 5-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)pent-1-en-3-one | 19.07 | C18H19O4 | 299.1281 | 137 | NR-1, NR-3, NE-4, NW-2, NW-3 |
| 30 | 2-(3,4-dihydroxy-5-methoxybenzylidene)-5-(-3,4-dimethoxystyryl)furan-3(2H)-one | 22.15 | C22H21O7 | 397.1262 | 191, 153 | NR-1, NR-2, NR-4, NE-1, NE-2, NE-3, NE-4, NW-3 |
| 31 | 2-(4-hydroxy-3-methoxybenzylidene)-5-(-4-hydroxystyryl)furan-3(2H)-one | 22.88 | C20H17O5 | 337.1054 | 137, 147 | NR-1, NR-2, NR-3, NR-4, NE-1, NE-2, NE-3, NE-4, NW-1, NW-2, NW-3, WR-1 |
| 32 | 2-(4-hydroxybenzylidene)-5-(-4-hydroxystyryl)furan-3(2H)-one | 26.16 | C19H15O4 | 307.0948 | 107, 147 | NR-1, NR-2, NR-4, NE-1, NE-2, NE-3, NE-4, NW-1, NW-2, NW-3, WR-1 |
| 33 | 4,4′-(3,5-dihydroxyheptane-1,7-diyl)bis(benzene-1,2-diol) | 28.14 | C19H25O6 | 349.164 | 149, 163, 177 | NE-1, NE-2, NE-4, NW-2, NW-3 |
1 Regions: Northern (NR), Northeastern (NE), Northwestern (NW), Western (WR).
Figure 2Structure and main fragments for compounds 22, 25 and 28.
Figure 3Fragmentation pathway of compound 4.
Figure 4Fragmentation pathway of compounds 14, 18 and 24.
Figure 5Fragmentation pathway of compounds 17 and 27.
Figure 6Fragmentation pathway for compounds 13, 15, 16.
Figure 7Fragmentation pathway for peaks 2, 26 and 29.
Figure 8FFragmentation pathways I and II for compounds 11 and 12.
Figure 9Fragmentation pathway of compounds 1, 10 and 23.
Figure 10Fragmentation pathways I and II for compounds 20, 33.
Figure 11Fragmentation pathways I and II for compounds 3 and 5.
Figure 12Fragmentation pathways I and II for compounds 6, 7, 8, 9, 19, 30, 31 and 32.
Total curcuminoid (TC) content in C. longa rhizomes.
| Product | CUR (mg/g) 1,2,3 | DMC (mg/g) | BDM (mg/g) 1,2,3 | TC (mg/g) 1,2,3 |
|---|---|---|---|---|
| NR-1 | 42.1 a,b ± 0.3 | 25.9 a,b ± 1.0 | 21.5 a,b,c ± 3.0 | 90.8 a,b ± 3.3 |
| NR-2 | 38.6 b,c ± 1.0 | 29.3 a,c ± 2.1 | 15.0 d,e ± 1.0 | 82.7 b,c ± 2.6 |
| NR-3 | 31.8 d ± 2.6 | 19.0 d ± 1.3 | 17.9 c,d ± 1.8 | 68.7 d ± 5.8 |
| NR-4 | 25.6 e ± 0.4 | 13.2 e ± 0.1 | 11.1 e ± 0.1 | 49.9 e ± 0.5 |
| NE-1 | 50.0 f ± 0.2 | 46.6 f ± 1.7 | 28.4 f ± 2.0 | 125.0 f ± 3.7 |
| NE-2 | 42.6 a,b ± 0.8 | 34.2 c ± 1.2 | 19.4 b,c,d ± 0.5 | 96.1 a ± 2.4 |
| NE-3 | 54.8 f ± 1.2 | 40.8 g ± 0.6 | 22.1 a,b,c ± 0.4 | 117.8 g ± 2.2 |
| NE-4 | 43.7 a ± 1.7 | 25.1 a,b ± 2.4 | 21.5 a,b ± 1.2 | 90.3 a ± 2.0 |
| NW-1 | 35.3 c,d ± 0.6 | 21.9 b,d ± 0.1 | 14.3 d,e ± 0.4 | 71.6 c,d ± 1.1 |
| NW-2 | 51.2 f ± 1.8 | 33.4 c ± 3.8 | 24.6 a,f ± 2.0 | 109.1 g ± 6.0 |
| NW-3 | 62.7 g ± 0.4 | 30.5 a,c ± 0.3 | 25.6 a,f ± 0.3 | 118.7 g ± 1.0 |
| WR-1 | 32.3 d ± 2.0 | 20.0 d ± 1.0 | 16.3 d ± 0.6 | 68.6 d ± 3.2 |
1 mg of curcuminoid/g dry material. 2 Values are expressed as mean ± standard deviation (S.D.). 3 Different superscript letters in the same column indicate that differences are significant at p < 0.05 using one-way analysis of variance (ANOVA) with a Tukey post hoc as the statistical test.
Figure 13UPLC-DAD chromatograms for samples: (a) NE-1, (b) NR-1, (c) NW-1 and (d) WR-1, showing the three quantified curcuminoids CUR, DMC and BDM.
Figure 14Percentage contents of CUR, DMC and BDM curcuminoids by UPLC-DAD for C. longa extracts.
Folin–Ciocalteu (FC) reducing capacity results for extracts of C. longa rhizomes.
| Product | FC (mg GAE/g) 1,2,3 | Product | FC (mg GAE/g) 1,2,3 |
|---|---|---|---|
| NR-1 | 250.0 a ± 6.5 | NE-3 | 281.9 c ± 1.5 |
| NR-2 | 224.5 b ± 5.4 | NE-4 | 287.8 c ± 4.8 |
| NR-3 | 228.0 b ± 5.6 | NW-1 | 219.8 b ± 2.3 |
| NR-4 | 214.8 b ± 4.7 | NW-2 | 260.2 a,d ± 3.8 |
| NE-1 | 278.8 c ± 2.0 | NW-3 | 301.0 e ± 3.3 |
| NE-2 | 267.1 d ± 2.6 | WR-1 | 229.2 b ± 0.3 |
1 mg of gallic acid equivalent (GAE)/g extract. 2 Values are expressed as mean ± standard deviation (S.D.). 3 Different superscript letters indicate differences are significant at p < 0.05 using one-way analysis of variance (ANOVA) with a Tukey post hoc as statistical test.
Figure 15Correlation of Folin–Ciocalteu (FC) reducing capacity results and: (a) UPLC-DAD total curcuminoids (TC), (b) UPLC-DAD curcumin (CUR) contents.
DPPH antioxidant activity of extracts from C. longa rhizomes.
| Product | IC50 (µg/mL) 1,2 | Product | IC50 (µg/mL) 1,2 |
|---|---|---|---|
| NR-1 | 21.22 a ± 0.19 | NE-3 | 19.04 f,g ± 0.65 |
| NR-2 | 23.32 b ± 0.25 | NE-4 | 18.51 h ± 0.09 |
| NR-3 | 28.01 c ± 0.52 | NW-1 | 25.07 f ± 0.72 |
| NR-4 | 29.12 d ± 0.88 | NW-2 | 19.41 b ± 0.16 |
| NE-1 | 16.07 e ± 0.10 | NW-3 | 15.21 g ± 0.01 |
| NE-2 | 19.27 f,g ± 0.05 | WR-1 | 22.92 e ± 0.03 |
1 Values are expressed as mean ± standard deviation (S.D.). 2 Different superscript letters indicate that differences are significant at p < 0.05 using one-way analysis of variance (ANOVA) with a Tukey post hoc as statistical test.
Figure 16Correlation of antioxidant activity assessed by the DPPH method and: (a) Folin–Ciocalteu (FC) results; (b) Total curcuminoids (TC) content measured by UPLC-DAD; and (c) curcumin (CUR) content measured by UPLC-DAD.
NO scavenging activity of extracts from C. longa rhizomes.
| Product | IC50 (µg/mL) 1,2 | Product | IC50 (µg/mL) 1,2 |
|---|---|---|---|
| NR-1 | 73.9 a ± 1.4 | NE-3 | 69.0 a,b ± 4.6 |
| NR-2 | 78.4 a ± 5.9 | NE-4 | 65.5 a,b ± 1.0 |
| NR-3 | 81.9 a ± 4.1 | NW-1 | 79.2 a ± 5.2 |
| NR-4 | 78.5 a ± 2.3 | NW-2 | 67.9 a,b ± 4.0 |
| NE-1 | 54.3 b ± 0.4 | NW-3 | 52.5 b ± 4.1 |
| NE-2 | 68.1 a,b ± 3.3 | WR-1 | 69.7 a,b ± 1.4 |
1 Values are expressed as mean ± standard deviation (S.D.). 2 Different superscript letters indicate that IC50 differences are significant at p < 0.05 using one-way analysis of variance (ANOVA) with a Tukey post hoc as statistical test.
Figure 17NO scavenging activity of selected samples (n = 6) of extracts from C. longa rhizomes.
Figure 18Correlation of antioxidant activity assessed through the Nitric Oxide (NO) radical scavenging and: (a) DPPH antioxidant activity (b) Folin–Ciocalteu (FC) reducing capacity results; (c) total curcuminoids (TC) content determined by UPLC-DAD.
Figure 19Graphic representation of the plane defined by the two first principal components (PC1 and PC2) deriving from the PCA analysis of C. longa rhizomes (n = 12) contents. Regions: Northeastern (NE), Northern (NR), Northwestern (NW), Western (WR).